These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32182653)

  • 1. Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat.
    Dahlgren D; Cano-Cebrián MJ; Olander T; Hedeland M; Sjöblom M; Lennernäs H
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32182653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats.
    Dahlgren D; Olander T; Sjöblom M; Hedeland M; Lennernäs H
    Acta Pharm Sin B; 2021 Jun; 11(6):1667-1675. PubMed ID: 34221875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin.
    Dahlgren D; Sjöblom M; Hedeland M; Lennernäs H
    Pharmaceutics; 2020 Jan; 12(2):. PubMed ID: 31991924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker
    Dahlgren D; Roos C; Lundqvist A; Tannergren C; Langguth P; Sjöblom M; Sjögren E; Lennernäs H
    Mol Pharm; 2017 Dec; 14(12):4243-4251. PubMed ID: 28737406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
    Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
    Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model.
    Dahlgren D; Roos C; Peters K; Lundqvist A; Tannergren C; Sjögren E; Sjöblom M; Lennernäs H
    Eur J Pharm Biopharm; 2019 Sep; 142():31-37. PubMed ID: 31201856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms.
    Dahlgren D; Roos C; Johansson P; Lundqvist A; Tannergren C; Abrahamsson B; Sjögren E; Lennernäs H
    Mol Pharm; 2016 Sep; 13(9):3022-33. PubMed ID: 27500599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
    Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes.
    Yamamoto A; Okagawa T; Kotani A; Uchiyama T; Shimura T; Tabata S; Kondo S; Muranishi S
    J Pharm Pharmacol; 1997 Nov; 49(11):1057-61. PubMed ID: 9401937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent effects on small intestinal transport by absorption-modifying excipients.
    Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
    Eur J Pharm Biopharm; 2018 Nov; 132():19-28. PubMed ID: 30179738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of permeability enhancers on paracellular permeability of acyclovir.
    Ates M; Kaynak MS; Sahin S
    J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Intestinal Permeability in Rats: A Comparison of Methods.
    Roos C; Dahlgren D; Sjögren E; Tannergren C; Abrahamsson B; Lennernäs H
    Mol Pharm; 2017 Dec; 14(12):4252-4261. PubMed ID: 28920690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions.
    Roos C; Dahlgren D; Sjögren E; Sjöblom M; Hedeland M; Lennernäs H
    Eur J Pharm Biopharm; 2019 Sep; 142():387-395. PubMed ID: 31306752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
    Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
    World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional Intestinal Permeability of Three Model Drugs in Human.
    Dahlgren D; Roos C; Lundqvist A; Abrahamsson B; Tannergren C; Hellström PM; Sjögren E; Lennernäs H
    Mol Pharm; 2016 Sep; 13(9):3013-21. PubMed ID: 27504798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs.
    Dahlgren D; Roos C; Johansson P; Tannergren C; Lundqvist A; Langguth P; Sjöblom M; Sjögren E; Lennernäs H
    Int J Pharm; 2018 Aug; 547(1-2):158-168. PubMed ID: 29758344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of oral permeation enhancers with lipid membranes in simulated intestinal environments.
    Larsen NW; Kostrikov S; Hansen MB; Hjørringgaard CU; Larsen NB; Andresen TL; Kristensen K
    Int J Pharm; 2024 Apr; 654():123957. PubMed ID: 38430950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
    Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
    Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
    Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
    Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
    Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
    Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.